Clinical Trial

Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated September 28, 2023 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Acute Variceal Bleeding (AVB) in patients with liver cirrhosis is a common clinical critical disease. There is little evidence for the effect of proton pump inhibitor (PPI) use in patients with AVB, and there is no study on the efficacy of PPI combined with standard therapy in patients with AVB.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-11-12.
Trial Details
NCT Number NCT05624229
Lead Sponsor West China Hospital
Conditions Upper Gastrointestinal Hemorrhage
Enrollment 672 participants
Start Date 2023-10-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-09-28